These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15887972)

  • 21. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of a new series of potent and selective linear tachykinin NK2 receptor antagonists.
    Fedi V; Altamura M; Catalioto RM; Giannotti D; Giolitti A; Giuliani S; Guidi A; Harmat NJ; Lecci A; Meini S; Nannicini R; Pasqui F; Tramontana M; Triolo A; Maggi CA
    J Med Chem; 2007 Oct; 50(20):4793-807. PubMed ID: 17850056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphiceptin analogues containing a dipeptide mimetic structure: an investigation on the bioactive topology at the mu-receptor.
    Grieco P; Giusti L; Carotenuto A; Campiglia P; Calderone V; Lama T; Gomez-Monterrey I; Tartaro G; Mazzoni MR; Novellino E
    J Med Chem; 2005 May; 48(9):3153-63. PubMed ID: 15857121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid agonist and antagonist effects of configurational stereoisomers of 3-(dimethylamino)-2,2-dimethyl-7-hydroxy-1-tetralol.
    Lippman DA; Matos FF; Shirachi DY
    NIDA Res Monogr; 1986; 75():213-6. PubMed ID: 3123937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of deltorphin I analogues and preliminary characterisation of mu-receptor binding.
    Paynter H; Sutton R; Mole EJ
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):262S. PubMed ID: 8224414
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic).
    Cai TB; Zou Z; Thomas JB; Brieaddy L; Navarro HA; Carroll FI
    J Med Chem; 2008 Mar; 51(6):1849-60. PubMed ID: 18307295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds.
    Ballet S; Marczak ED; Feytens D; Salvadori S; Sasaki Y; Abell AD; Lazarus LH; Balboni G; Tourwé D
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1610-3. PubMed ID: 20137938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a new scaffold for opioid receptor antagonism based on the 2-amino-1,1-dimethyl-7-hydroxytetralin pharmacophore.
    Grundt P; Williams IA; Lewis JW; Husbands SM
    J Med Chem; 2004 Oct; 47(21):5069-75. PubMed ID: 15456250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif.
    Jagerovic N; Hernandez-Folgado L; Alkorta I; Goya P; Navarro M; Serrano A; Rodriguez de Fonseca F; Dannert MT; Alsasua A; Suardiaz M; Pascual D; Martín MI
    J Med Chem; 2004 May; 47(11):2939-42. PubMed ID: 15139773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of highly potent and selective dynorphin A analogues as new medicines.
    Lung FD; Chen CH; Liu JH
    J Pept Res; 2005 Nov; 66(5):263-76. PubMed ID: 16218994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel, achiral 1,3,4-benzotriazepine analogues of 1,4-benzodiazepine-based CCK(2) antagonists that display high selectivity over CCK(1) receptors.
    McDonald IM; Austin C; Buck IM; Dunstone DJ; Griffin E; Harper EA; Hull RA; Kalindjian SB; Linney ID; Low CM; Pether MJ; Spencer J; Wright PT; Adatia T; Bashall A
    J Med Chem; 2006 Apr; 49(7):2253-61. PubMed ID: 16570921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.
    Micheli F; Bonanomi G; Braggio S; Capelli AM; Celestini P; Damiani F; Di Fabio R; Donati D; Gagliardi S; Gentile G; Hamprecht D; Petrone M; Radaelli S; Tedesco G; Terreni S; Worby A; Heidbreder C
    Bioorg Med Chem Lett; 2008 Feb; 18(3):901-7. PubMed ID: 18248991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.
    Micheli F; Bonanomi G; Braggio S; Capelli AM; Damiani F; Di Fabio R; Donati D; Gentile G; Hamprecht D; Perini O; Petrone M; Tedesco G; Terreni S; Worby A; Heidbreder C
    Bioorg Med Chem Lett; 2008 Feb; 18(3):908-12. PubMed ID: 18178090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208.
    Dolle RE; Michaut M; Martinez-Teipel B; Seida PR; Ajello CW; Muller AL; DeHaven RN; Carroll PJ
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3647-50. PubMed ID: 19464172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and structure-activity relationships of a new series of 2alpha-substituted trans-4,5-dimethyl-4-(3-hydroxyphenyl)piperidine as mu-selective opioid antagonists.
    Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; DeHaven RN; Dolle RE
    Bioorg Med Chem Lett; 2006 Feb; 16(4):864-8. PubMed ID: 16298525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulus-evoked opioid inhibition in guinea-pig longitudinal muscle-myenteric plexus strip is modulated by NMDA receptors.
    Donnerer J; Liebmann I
    Neurosci Lett; 2007 May; 419(1):74-7. PubMed ID: 17412512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.
    Peng X; Knapp BI; Bidlack JM; Neumeyer JL
    J Med Chem; 2006 Jan; 49(1):256-62. PubMed ID: 16392810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1.
    Takeuchi K; Holloway WG; McKinzie JH; Suter TM; Statnick MA; Surface PL; Emmerson PJ; Thomas EM; Siegel MG; Matt JE; Wolfe CN; Mitch CH
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5349-52. PubMed ID: 17720493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nb-benzoyltryptamine derivatives with relaxant activity in guinea-pig ileum.
    Gutierrez SJ; de S Claudino F; Da Silva BA; Câmara CA; de Almeida RN; de Fátima V de Souza M; Da Silva MS; Da-Cunha EV; Barbosa-Filho JM
    Farmaco; 2005; 60(6-7):475-7. PubMed ID: 15913615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
    Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
    Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.